Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 341

1.

A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease.

Deane KH, Whurr R, Playford ED, Ben-Shlomo Y, Clarke CE.

Cochrane Database Syst Rev. 2001;(2):CD002814. Review. Update in: Cochrane Database Syst Rev. 2012;8:CD002814.

PMID:
11406045
2.

Speech and language therapy for dysarthria in Parkinson's disease.

Deane KH, Whurr R, Playford ED, Ben-Shlomo Y, Clarke CE.

Cochrane Database Syst Rev. 2001;(2):CD002812. Review. Update in: Cochrane Database Syst Rev. 2012;8:CD002812.

PMID:
11406044
3.

Physiotherapy for patients with Parkinson's Disease: a comparison of techniques.

Deane KH, Jones D, Playford ED, Ben-Shlomo Y, Clarke CE.

Cochrane Database Syst Rev. 2001;(3):CD002817. Review. Update in: Cochrane Database Syst Rev. 2012;7:CD002817.

PMID:
11687029
4.

A comparison of physiotherapy techniques for patients with Parkinson's disease.

Deane KH, Jones D, Ellis-Hill C, Clarke CE, Playford ED, Ben-Shlomo Y.

Cochrane Database Syst Rev. 2001;(1):CD002815. Review. Update in: Cochrane Database Syst Rev. 2014;6:CD002815.

PMID:
11279765
5.

Occupational therapy for patients with Parkinson's disease.

Deane KH, Ellis-Hill C, Playford ED, Ben-Shlomo Y, Clarke CE.

Cochrane Database Syst Rev. 2001;(3):CD002813. Review. Update in: Cochrane Database Syst Rev. 2007;(3):CD002813.

PMID:
11687028
6.

Occupational therapy for patients with Parkinson's disease.

Dixon L, Duncan D, Johnson P, Kirkby L, O'Connell H, Taylor H, Deane KH.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD002813. Review.

PMID:
17636709
7.

Non-pharmacological therapies for dysphagia in Parkinson's disease.

Deane KH, Whurr R, Clarke CE, Playford ED, Ben-Shlomo Y.

Cochrane Database Syst Rev. 2001;(1):CD002816. Review.

PMID:
11279766
8.

Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease.

Herd CP, Tomlinson CL, Deane KH, Brady MC, Smith CH, Sackley CM, Clarke CE.

Cochrane Database Syst Rev. 2012 Aug 15;(8):CD002812. doi: 10.1002/14651858.CD002812.pub2. Review.

PMID:
22895930
9.

Amantadine in Parkinson's disease.

Crosby N, Deane KH, Clarke CE.

Cochrane Database Syst Rev. 2003;(1):CD003468. Review.

PMID:
12535476
10.

Comparison of speech and language therapy techniques for speech problems in Parkinson's disease.

Herd CP, Tomlinson CL, Deane KH, Brady MC, Smith CH, Sackley CM, Clarke CE.

Cochrane Database Syst Rev. 2012 Aug 15;(8):CD002814. doi: 10.1002/14651858.CD002814.pub2. Review.

PMID:
22895931
11.

Beta-blocker therapy for tremor in Parkinson's disease.

Crosby NJ, Deane KH, Clarke CE.

Cochrane Database Syst Rev. 2003;(1):CD003361. Review.

PMID:
12535472
12.

Amantadine for dyskinesia in Parkinson's disease.

Crosby NJ, Deane KH, Clarke CE.

Cochrane Database Syst Rev. 2003;(2):CD003467. Review.

PMID:
12804468
13.

Systematic review of paramedical therapies for Parkinson's disease.

Deane KH, Ellis-Hill C, Jones D, Whurr R, Ben-Shlomo Y, Playford ED, Clarke CE.

Mov Disord. 2002 Sep;17(5):984-91. Review.

PMID:
12360547
14.

Anticholinergics for symptomatic management of Parkinson's disease.

Katzenschlager R, Sampaio C, Costa J, Lees A.

Cochrane Database Syst Rev. 2003;(2):CD003735. Review.

PMID:
12804486
15.

Speech and language therapy for dysarthria due to non-progressive brain damage.

Sellars C, Hughes T, Langhorne P.

Cochrane Database Syst Rev. 2002;(4):CD002088. Review. Update in: Cochrane Database Syst Rev. 2005;(3):CD002088.

PMID:
12519567
16.

Speech and language therapy for dysarthria due to non-progressive brain damage.

Sellars C, Hughes T, Langhorne P.

Cochrane Database Syst Rev. 2001;(2):CD002088. Review. Update in: Cochrane Database Syst Rev. 2002;(4):CD002088.

PMID:
11406032
17.

Therapies for depression in Parkinson's disease.

Shabnam GN, Th C, Kho D, H R, Ce C.

Cochrane Database Syst Rev. 2003;(3):CD003465. Review.

PMID:
12917968
18.

Ropinirole for levodopa-induced complications in Parkinson's disease.

Clarke CE, Deane KH.

Cochrane Database Syst Rev. 2001;(1):CD001516. Review.

PMID:
11279718
19.

Ropinirole for levodopa-induced complications in Parkinson's disease.

Clarke CE, Deane KH.

Cochrane Database Syst Rev. 2000;(3):CD001516. Review. Update in: Cochrane Database Syst Rev. 2001;(1):CD001516.

PMID:
10908503
20.

Cabergoline for levodopa-induced complications in Parkinson's disease.

Clarke CE, Deane KH.

Cochrane Database Syst Rev. 2001;(1):CD001518. Review.

PMID:
11279720

Supplemental Content

Support Center